Details for New Drug Application (NDA): 071795
✉ Email this page to a colleague
The generic ingredient in SULINDAC is sulindac. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulindac profile page.
Summary for 071795
Tradename: | SULINDAC |
Applicant: | Watson Labs |
Ingredient: | sulindac |
Patents: | 0 |
Pharmacology for NDA: 071795
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 071795
Suppliers and Packaging for NDA: 071795
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SULINDAC | sulindac | TABLET;ORAL | 071795 | ANDA | Actavis Pharma, Inc. | 0591-5660 | 0591-5660-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5660-01) |
SULINDAC | sulindac | TABLET;ORAL | 071795 | ANDA | Actavis Pharma, Inc. | 0591-5660 | 0591-5660-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0591-5660-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Apr 3, 1990 | TE: | AB | RLD: | No |
Complete Access Available with Subscription